Literature DB >> 18945446

Recurrent varicella zoster virus myelopathy.

Don Gilden1, Maria A Nagel, Richard M Ransohoff, Randall J Cohrs, Ravi Mahalingam, Jody L Tanabe.   

Abstract

Myelopathy is an uncommon complication of VZV infection and may develop in the absence of rash. We report the rare recurrence of myelopathy in an immunocompetent adult who initially developed myelopathy after ophthalmic-distribution zoster. Recurrent myelopathy two years later caused by VZV was verified by the presence of new-onset clinical symptoms and signs consistent with myelopathy, new lesions in the spinal cord detected by MRI, and evidence of intrathecal synthesis of anti-VZV IgG antibody in CSF. After virological verification and antiviral therapy, myelopathy did not recur and anti-VZV IgG antibody could not be detected in CSF. In contrast to earlier cases of recurrent VZV myelopathy in immunocompetent adults that developed weeks to months after the first episode of myelopathy, this is the first instance of recurrence years later.

Entities:  

Mesh:

Year:  2008        PMID: 18945446      PMCID: PMC2828365          DOI: 10.1016/j.jns.2008.09.025

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Two patients with unusual forms of varicella-zoster virus vasculopathy.

Authors:  Donald H Gilden; Howard L Lipton; James S Wolf; William Akenbrandt; John E Smith; Ravi Mahalingam; Bagher Forghani
Journal:  N Engl J Med       Date:  2002-11-07       Impact factor: 91.245

2.  Recurrent varicella-zoster virus myelitis in an immunocompetent patient.

Authors:  H Jacobus Gilhuis; Caroline E Visser; Peter Portegies
Journal:  Eur Neurol       Date:  2004-08-18       Impact factor: 1.710

3.  VZV spinal cord infarction identified by diffusion-weighted MRI (DWI).

Authors:  H T Orme; A G Smith; M A Nagel; R J Bert; T S Mickelson; D H Gilden
Journal:  Neurology       Date:  2007-07-24       Impact factor: 9.910

4.  Zoster myelitis: improvement with antiviral therapy in two cases.

Authors:  S M de Silva; A S Mark; D H Gilden; R Mahalingam; M Balish; F Sandbrink; S Houff
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

5.  Recurrent herpes zoster myelitis treated with human interferon alpha: a case report.

Authors:  T Nakano; E Awaki; S Araga; H Takai; K Inoue; K Takahashi
Journal:  Acta Neurol Scand       Date:  1992-05       Impact factor: 3.209

6.  Varicella-zoster virus myelitis: an expanding spectrum.

Authors:  D H Gilden; B R Beinlich; E M Rubinstien; E Stommel; R Swenson; D Rubinstein; R Mahalingam
Journal:  Neurology       Date:  1994-10       Impact factor: 9.910

Review 7.  The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.

Authors:  M A Nagel; R J Cohrs; R Mahalingam; M C Wellish; B Forghani; A Schiller; J E Safdieh; E Kamenkovich; L W Ostrow; M Levy; B Greenberg; A N Russman; I Katzan; C J Gardner; M Häusler; R Nau; T Saraya; H Wada; H Goto; M de Martino; M Ueno; W D Brown; C Terborg; D H Gilden
Journal:  Neurology       Date:  2008-03-11       Impact factor: 9.910

8.  Recurrent herpes zoster myelitis.

Authors:  J S Baik; W C Kim; J H Heo; H Y Zheng
Journal:  J Korean Med Sci       Date:  1997-08       Impact factor: 2.153

  8 in total
  9 in total

Review 1.  Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature.

Authors:  Aaron Haug; Ravi Mahalingam; Randall J Cohrs; D Scott Schmid; John R Corboy; Don Gilden
Journal:  J Neurol Sci       Date:  2010-02-19       Impact factor: 3.181

Review 2.  Herpes zoster and the search for an effective vaccine.

Authors:  N Arnold; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

3.  Zoster sine herpete: virologic verification by detection of anti-VZV IgG antibody in CSF.

Authors:  D T Blumenthal; E Shacham-Shmueli; F Bokstein; D S Schmid; R J Cohrs; M A Nagel; R Mahalingam; D Gilden
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

Review 4.  Neurological disease produced by varicella zoster virus reactivation without rash.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

5.  A woman with acute headache and sacral dermatomal numbness.

Authors:  R N Gunson; C Aitken; Don Gilden
Journal:  J Clin Virol       Date:  2010-12-03       Impact factor: 3.168

6.  Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman.

Authors:  Ali A Habib; Don Gilden; D Scott Schmid; Joseph E Safdieh
Journal:  J Neurovirol       Date:  2009-04       Impact factor: 2.643

7.  Varicella zoster virus pneumonitis and brainstem encephalitis without skin rash in an immunocompetent adult.

Authors:  Ramachandiran Nandhagopal; Nelly Khmeleva; B Jayakrishnan; Teresa White; Faisal Al Azri; Jojy George; Anna Heintzman; Khalfan Al Zeedy; Lucy Rorke-Adams; Arunodaya R Gujjar; D Scott Schmid; Abdullah Al-Asmi; Maria A Nagel; Poovathoor Chacko Jacob; Don Gilden
Journal:  Open Forum Infect Dis       Date:  2014-08-06       Impact factor: 3.835

Review 8.  Zoster sine herpete: a review.

Authors:  Junli Zhou; Juan Li; Lulin Ma; Song Cao
Journal:  Korean J Pain       Date:  2020-07-01

9.  Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate.

Authors:  Brandy B Ma; Lyle W Ostrow; Scott D Newsome
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.